Hear Talk Audio
Multiple Myeloma: An Insight into Early Intervention and Personalized Therapies
Myeloma patients are definitely living longer. A decade ago the median survival was 3 to 4 years, while now it is in the range of 8 to 10 years. With all the new drugs and treatments that have been approved, it is possible to control the disease for a longer period of time. We are talking to Dr. Shaji Kumar to explore the treatment potential of intervening early in the disease and also touch upon how personalized therapies can help in managing myeloma efficiently.